AIM ImmunoTech Inc.
AIM
$2.55
-$0.05-1.92%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 121.00K | 146.00K | 170.00K | 190.00K | 201.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 121.00K | 146.00K | 170.00K | 190.00K | 201.00K |
| Cost of Revenue | 35.00K | 33.00K | 31.00K | 36.00K | 58.00K |
| Gross Profit | 86.00K | 113.00K | 139.00K | 154.00K | 143.00K |
| SG&A Expenses | 11.54M | 12.64M | 13.90M | 20.54M | 22.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.73M | 17.80M | 19.94M | 28.11M | 31.79M |
| Operating Income | -16.61M | -17.66M | -19.77M | -27.92M | -31.59M |
| Income Before Tax | -16.17M | -15.21M | -17.32M | -23.93M | -28.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.17 | -15.21 | -17.32 | -23.93 | -28.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.17M | -15.21M | -17.32M | -23.93M | -28.05M |
| EBIT | -16.61M | -17.66M | -19.77M | -27.92M | -31.59M |
| EBITDA | -16.37M | -17.41M | -19.53M | -27.68M | -31.36M |
| EPS Basic | -24.89 | -24.69 | -31.25 | -47.81 | -57.57 |
| Normalized Basic EPS | -15.69 | -15.47 | -19.42 | -30.48 | -35.93 |
| EPS Diluted | -24.89 | -24.69 | -31.25 | -47.81 | -57.57 |
| Normalized Diluted EPS | -15.69 | -15.47 | -19.42 | -30.48 | -35.93 |
| Average Basic Shares Outstanding | 194.70M | 194.47M | 173.39M | 158.11M | 148.98M |
| Average Diluted Shares Outstanding | 194.70M | 194.47M | 173.39M | 158.11M | 148.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |